MARKET WIREYahoo Finance • 1d ago
Q2 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Earns Top MarksYahoo Finance report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
Why RDNT Stock slipped -0.53% Today — RQD Quant Desk Flash
$73.10 -0.53% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $72.89
RadNet Inc. (RDNT) carries a Roarable Rating of D+ (Sell) with 57/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D+ • SELL / AVOID
Cap $5.78B
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on RDNT Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is RDNT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, RadNet Inc. (NASDAQ: RDNT) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 57/100 at a spot price of $73.10 (-0.53% 1D, market cap $5.78B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 14/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 11/20, and Executive Insider Alignment 10/20. Across 1015 tracked Health Care issuers, RDNT ranks #188 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does RDNT compare to BLLN and GRAL in the Health Care sector?
▼
Within the Health Care sector (Medical Specialities), RDNT carries a Roarable D+ (57/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of 3.5%. By comparison, BLLN (BillionToOne Inc.) holds a B- grade (70/100 RQD, P/E N/A, ROIC 2.9%, cap $5.35B) and GRAL (GRAIL Inc.) posts a D+ grade (54/100 RQD, P/E N/A, ROIC -18.0%, cap $6.41B). Among the 5-stock peer group, CON leads on earnings multiple (31.6x) while CON leads on capital efficiency (19.7% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for RDNT?
▼
Per RDNT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000790526), RadNet Inc. generated $2.04B in revenue (+11.5% YoY), -$18.6M in net income, and $298.8M in free cash flow against $3.76B in total assets and $1.06B in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $72.89 (-0.29%)🧬 Cannibal Buyback (-0.68% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 14.6% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 57/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.2% avg 90D alpha vs SPY • 52.2% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D+
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw C- · Rk D+
Each axis scored 0–20
12M PRICE TARGET CONE-0.5% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for RDNT)Realized 20D OHLCV Swing Band: ±6.6%
Deterministic 5-Pillar Attribution (57/100 Composite)
🔍 WHY RDNT SCORES 57/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+14/20 pts (25% of score)
20D Institutional Volume Accumulation (±6.6% realized swing band)
▲ #2 Bullish Driver: Cash Engine Quality+12/20 pts (21% of score)
SEC XBRL FY 2025 (10-K): 14.6% FCF Margin ($298.8M FCF) & 52% Gross Margin
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution10/20 pts (-10 pt drag)
Cannibal Buyback (-0.68% YoY Shares) & executive Form 4 sales trim 10 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$71.49-3.1% Next Q
49
Q2 (-2Q)Grade C-$69.27+1.1% Next Q
52
Q3 (-1Q)Grade C-$70.05+4.4% Next Q
54
CurrentGrade D+$73.10-0.2% Hist 90D α
57
Trajectory: D (49) → D+ (57)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the RDNT Bull Thesis Could Fail
Even with a 57/100 (D+) score, RDNT faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Company executives have done more routine share selling than personal cash buying lately.
⚠️ Forensic Kill-Switch #2
Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($72.49) or 200D SMA ($65.14) invalidates the momentum regime and cuts Target Base ($72.77) toward Bear Floor ($56.76).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $RDNT• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “RDNT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why RDNT Stock slipped -0.53% Today — RQD Quant Desk Flash
RadNet Inc. (RDNT) slipped -0.53% to $73.10, trading at 64% of its 52-week range ($50.82 – $85.84). Stretched risk/reward at current multiples (4% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 64% of its 52-week range ($50.82 – $85.84) with RSI-14 at 57.9 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±6.6% around $73.10 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 52% gross margin and $298.8M annual free cash flow.
Live RDNT Headlines & Catalysts
MARKET WIRETradingView • 1d ago
RadNet, Inc. Estimates – NASDAQ:RDNTTradingView report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESeeking Alpha • 1d ago
RadNet, Inc. (RDNT) ONRAD, Inc., - M&A Call - Slideshow (NASDAQ:RDNT) 2026-10-27Seeking Alpha report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
MARKET WIREBenzinga • 1d ago
Here’s How Much You Would Have Made Owning RadNet Stock In The Last 15 YearsBenzinga report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 1d ago
3 Reasons to avoid RDNT and 1 stock to buy insteadYahoo Finance report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
CATALYSTGuruFocus • 1d ago
RadNet Inc (RDNT) Shares Surge 4.0% -- What GF Score of 81 Tells InvestorsGuruFocus report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
CATALYSTSimply Wall St • 1d ago
Earnings Beat Might Change The Case For Investing In RadNet Stock (RDNT)Simply Wall St report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 1d ago
A radiology services company supporting more than 225 hospital facilities is expected to join RadNet.Stock Titan report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo • 5d ago
RadNet, Inc. Announces Date of its Third Quarter 2026 Financial Results Conference CallLOS ANGELES, Oct. 29, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imagi
MARKET WIREYahoo • 6d ago
RadNet expands into teleradiology with $350M Onrad dealThe acquisition, which will give RadNet a new professional services unit, is expected to help hospitals solve challenges with radiology coverage.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring RDNT)
- ✓Walkthrough of RDNT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
RDNT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +25.47%▲ ASCENDING CHANNEL
2026-11-03O $73.65H $73.65L $73.10C $73.10VOL 571.7K
RES: $81.01SUP: $68.68SMA50: $72.49SMA200: $65.14
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
RDNT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
48.0%/yr Implied 5Y Growth
vs. +11.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on RDNT today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for RDNT. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for RDNT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (RDNT)
Health Care Rank #188 of 1015
⚔️ BLLN vs RDNT Full Matrix →
1. Head-to-Head Health Care Peer Comparison (RDNT vs. BLLN, GRAL, CON, CDNA)
Industry: Medical Specialities (41 Tracked Issuers)Across 1015 tracked Health Care securities in the Roarable RQD universe, RadNet Inc. (RDNT) ranks #188 by composite RQD confidence (57/100, grade D+) and #147 by equity capitalization ($5.78B). Within this direct 5-issuer industry benchmark cohort, CON leads on earnings valuation at 31.6x trailing P/E, while CON leads on capital efficiency and profitability with 19.7% ROIC and — gross margin. CDNA currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with RDNT at 57/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| RDNT
ACTIVE
RadNet Inc. | D+ | 57/100 | — | — | 3.5% | -0.53% | $5.78B | Benchmark Subject |
| BLLN BillionToOne Inc. | B- | 70/100 | — | 68.3% | 2.9% | -2.57% | $5.35B | /blln-vs-rdnt → |
| GRAL GRAIL Inc. | D+ | 54/100 | — | — | -18.0% | -6.74% | $6.41B | /gral-vs-rdnt → |
| CON Concentra Group Holdings Parent Inc. | C+ | 68/100 | 31.6x | — | 19.7% | -0.12% | $5.15B | /con-vs-rdnt → |
| CDNA CareDx Inc. | B- | 71/100 | — | — | -8.2% | -1.75% | $4.59B | /cdna-vs-rdnt → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000790526 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), RadNet Inc. (RDNT) reported GAAP revenue of $2.04B (+11.5% vs. FY2024 revenue of $1.83B , and +26.2% cumulative change since FY2023) , GAAP net income of -$18.6M, operating cash flow of $298.8M, and free cash flow of $298.8M (+28.2% YoY). On the balance sheet, RDNT closed FY2025 with $3.76B in total assets against $1.06B in total debt (Altman Z-Score: 2.15, Piotroski F-Score: 6/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $2.04B | -$18.6M | $298.8M | $298.8M | $3.76B | $1.06B |
| FY2024 (FY) | 2024-12-31 | $1.83B | $2.8M | $233.0M | $233.0M | $3.29B | $991.6M |
| FY2023 (FY) | 2023-12-31 | $1.62B | $3.0M | $220.9M | $220.9M | — | — |
3. RDNT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs RDNT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, RadNet Inc. (NASDAQ: RDNT) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 57/100 at a spot price of $73.10 (-0.53% 1D, market cap $5.78B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 14/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 11/20, and Executive Insider Alignment 10/20. Across 1015 tracked Health Care issuers, RDNT ranks #188 in composite RQD confidence.
How does RDNT compare to BLLN and GRAL in the Health Care sector?
Within the Health Care sector (Medical Specialities), RDNT carries a Roarable D+ (57/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of 3.5%. By comparison, BLLN (BillionToOne Inc.) holds a B- grade (70/100 RQD, P/E N/A, ROIC 2.9%, cap $5.35B) and GRAL (GRAIL Inc.) posts a D+ grade (54/100 RQD, P/E N/A, ROIC -18.0%, cap $6.41B). Among the 5-stock peer group, CON leads on earnings multiple (31.6x) while CON leads on capital efficiency (19.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for RDNT?
Per RDNT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000790526), RadNet Inc. generated $2.04B in revenue (+11.5% YoY), -$18.6M in net income, and $298.8M in free cash flow against $3.76B in total assets and $1.06B in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is RDNT trading relative to its 50-day, 200-day, and 52-week technical levels?
RDNT last traded at $73.10 (-0.53% on volume of 960,789 shares), positioning the stock +0.84% above its 50-day simple moving average ($72.49) and +12.22% above its 200-day simple moving average ($65.14). Across its 52-week range of $50.82 to $85.84, RDNT sits at the 63.6% percentile with a 14-day RSI of 57.9 (BULLISH MOMENTUM) and an implied next-earnings move of ±6.6% ($68.28 to $77.92).
ROARABLE RATING BRIEF • RQD 57/100 (D+)
✓ SEC XBRL & RQD VERIFIED
RDNT — RadNet Inc.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
RadNet Inc. (RDNT) earns a live Roarable RQD composite score of 57/100, corresponding to a D+ letter grade (Roarable Sell) at a spot price of $73.10 (-0.53% 1D, market capitalization $5.78B).
- Fundamental Cash Engine (12/20): Anchored by return on invested capital (ROIC) of 3.5%, gross margin of —, operating margin of 3.0%, and free cash flow yield of 5.16%.
- Whale 13F & Options Flow (14/20) + Insider Conviction (10/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (11/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of 2.15, Piotroski F-Score of 6/9, and Debt/Equity of 0.98x.
2. Business Model, Unit Margins & SEC Financial Trajectory
RadNet Inc. Is a NASDAQ-listed issuer classified in the Health Care sector and the Medical Specialities industry,..8B.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), RadNet Inc. (RDNT) reported $2.04B in annual revenue (up from $1.83B in FY2024, +11.5% YoY) and -$18.6M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($1.62B revenue, $3.0M net income) through FY2025, RDNT scaled operating cash flow to $298.8M and free cash flow to $298.8M, backed by $3.76B in total assets against $1.06B in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (D+ • RQD 57/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of 5.16% and institutional whale pillar of 14/20. With Fundamental Cash Engine at 12/20 and Institutional Whale Flow at 14/20, sustained execution supports upside toward the upper end of the $50.82 – $85.84 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation and 98.3x EV/EBITDA against 3.0% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
The source data therefore does not establish upstream suppliers, downstream customers, or sector correlations beyond the Health Care / Medical Specialities classification. An investor should note that second-order ripple effects cannot be mapped from the provided sources. The one cross-check the data permits is the M&A reference in the Seeking Alpha headline, which points to a possible corporate-action catalyst, but the source does not detail its counterparty or implications.
- Key Question #1: Can RDNT sustain or expand its 3.0% operating margin and 3.5% ROIC against Medical Specialities peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $2.04B and free cash flow of $298.8M, how will capital allocation balance growth reinvestment against $1.06B in total debt?
- Key Question #3: How sensitive is RDNT's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
RDNT Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for RadNet Inc. (RDNT) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 1d ago
Q2 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Earns Top Marks Yahoo Finance report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 1d ago
RadNet, Inc. Estimates – NASDAQ:RDNT TradingView report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Seeking Alpha • 1d ago
RadNet, Inc. (RDNT) ONRAD, Inc., - M&A Call - Slideshow (NASDAQ:RDNT) 2026-10-27 Seeking Alpha report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Benzinga • 1d ago
Here’s How Much You Would Have Made Owning RadNet Stock In The Last 15 Years Benzinga report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 1d ago
3 Reasons to avoid RDNT and 1 stock to buy instead Yahoo Finance report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST GuruFocus • 1d ago
RadNet Inc (RDNT) Shares Surge 4.0% -- What GF Score of 81 Tells Investors GuruFocus report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST Simply Wall St • 1d ago
Earnings Beat Might Change The Case For Investing In RadNet Stock (RDNT) Simply Wall St report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 1d ago
A radiology services company supporting more than 225 hospital facilities is expected to join RadNet. Stock Titan report covering RadNet Inc. (RDNT) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
RDNT Bull vs. Bear Conversation Board — What's Your Call at $73.10?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON RDNT 🐻 33% BEARISH CONVICTION
CA CashFlowKing RQD DEBATE OPENER • FCF Compounder Hunter 🐂 BULLISH
🎯 Target: $89.66 (+22.0%)
📌 Pinned Debate Macro Regime Fit (14/20) is the strongest pillar, with beta of 1.0 and a 5.16% FCF yield providing cash-based support against the stock
Picked up a starter position in RDNT in my $100K Virtual Cash book at $73.49. Macro Regime Fit (14/20) is the strongest pillar, with beta of 1.0 and a 5.16% FCF yield providing cash-based support against the stock's price.. Trading inside a $50.82–$85.84 52-week range with 5.16% FCF yield gives solid downside support if Medical Specialities multiples expand this quarter.
EarningsSniper 🐂 BULL
Both sides have a point here — RDNT's 10/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.
SH ShortSeller_Dan RQD DEBATE OPENER • Forensic Short Bias 🐻 BEARISH
🎯 Target: $57.32 (-22.0%)
Spot @ $73.49 An EV/EBITDA of 98.3 combined with a net margin of -0.9% and debt of $1.06B exceeding cash of $767.2M leaves little valuation cushion
Careful chasing RDNT at $73.49. An EV/EBITDA of 98.3 combined with a net margin of -0.9% and debt of $1.06B exceeding cash of $767.2M leaves little valuation cushion.. Gross margin is 0.0%, but operating margin is 3.0%, which shows SG&A and reinvestment are eating into bottom-line EPS. Target $57.32 on multiple compression.